Capricorn Systems Board Approves Amalgamation with Radical Bio-Organics Limited
Capricorn Systems Global Solutions Limited successfully concluded its board meeting on April 11, 2026, approving the scheme of amalgamation with Radical Bio-Organics Limited. The strategic merger combines Capricorn's commodity trading business with Radical Bio-Organics' distillery manufacturing operations, creating operational synergies and financial benefits through a 1:1 share exchange ratio.

*this image is generated using AI for illustrative purposes only.
Capricorn Systems Global Solutions Limited has successfully concluded its board meeting on April 11, 2026, approving the scheme of amalgamation with Radical Bio-Organics Limited. The meeting, which commenced at 4:30 p.m. and concluded at 5:05 p.m., marked the completion of the corporate restructuring initiative previously announced on April 08, 2026.
Board Meeting Outcome and Approval
The Board of Directors formally considered and approved the Scheme of Amalgamation of Radical Bio-Organics Limited (Transferor Company) with and into Capricorn Systems Global Solutions Limited (Transferee Company) along with their respective shareholders and creditors. The approval was communicated to BSE Limited under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
| Meeting Parameter: | Details |
|---|---|
| Meeting Date: | April 11, 2026 |
| Duration: | 4:30 p.m. to 5:05 p.m. |
| Primary Decision: | Amalgamation scheme approval |
| Share Exchange Ratio: | 1:1 |
| Regulatory Compliance: | SEBI Regulation 30 |
Financial Profile and Business Operations
The amalgamation brings together two entities with complementary business profiles. Capricorn Systems Global Solutions Limited, the listed transferee company, operates primarily in import, export, and commodity trading including crops, minerals, textiles, food and beverages, and manufactured goods, with minimal revenue from software services.
| Financial Metrics: | Capricorn Systems (Transferee) | Radical Bio-Organics (Transferor) |
|---|---|---|
| Total Assets: | ₹28,77,68,478 | ₹225,86,91,258 |
| Turnover: | ₹20,74,05,673 | ₹451,86,12,423 |
| Net Worth: | ₹26,32,66,281 | ₹71,79,91,705 |
Radical Bio-Organics Limited specializes in manufacturing Extra Neutral Alcohol (ENA), Impure Spirit (IS), Dried Distiller Grain with Soluble (DDGS), and Solid Carbon Dioxide (COâ‚‚).
Strategic Rationale and Benefits
The amalgamation is designed to achieve strategic business diversification and risk mitigation by providing the combined entity substantial entry into the high-growth manufacturing sector of distillery products. This move reduces reliance on volatile commodity trading business while offering more predictable revenue streams.
Key expected benefits include:
- Operational Synergies: Optimized procurement through consolidated purchasing power, streamlined logistics, and rationalization of common functions
- Cost Synergies: Elimination of overlapping functions in administration, finance, human resources, and information technology
- Financial Benefits: Strengthened financial profile with higher revenues, improved profitability, and enhanced cash flows
- Market Position: Enhanced market capitalization and improved share liquidity through diversification
Share Exchange and Implementation
The approved scheme establishes a 1:1 share exchange ratio, where shareholders of Radical Bio-Organics Limited will receive one fully paid-up equity share of Capricorn Systems Global Solutions Limited for every one fully paid-up equity share held in the transferor company. Upon scheme effectiveness, all equity shares of Radical Bio-Organics Limited will stand extinguished.
The transaction does not fall within related party transactions, ensuring arm's length compliance. The combined entity's IT department will play a crucial role in supporting both commodity trading operations through real-time market tracking and manufacturing processes through automated production and supply chain management systems.
How will the significant size difference between the companies (Radical Bio-Organics having 15x higher turnover) affect the integration timeline and operational challenges?
What regulatory approvals from NCLT, shareholders, and creditors are still pending for this amalgamation scheme to become effective?
Will Capricorn Systems need to invest in additional manufacturing capacity or technology upgrades to fully leverage Radical Bio-Organics' distillery operations?




























